Merus N.V. (MRUS)
Latest MRUS Insider Trades
About Merus N.V. (MRUS)
Merus N.V. is an SEC registrant, filing under CIK 0001651311, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
90-Day SEC Filing Activity
No Form 4 activity for MRUS in the last 90 days.
MRUS Insider Transactions (Form 4)
14522 Form 4 filings on record, the earliest from May 22, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| A/S Genmab | Open-market purchase | Common Shares, nominal value EUR 0.09 per share | 2,978 |
MRUS Insider Trading - FAQ
What is the latest insider trade for MRUS?
Merus N.V. (MRUS) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-30. The full record for MRUS runs to 22 Form 4 filings, the earliest from 2025-05-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying MRUS stock?
No insider purchases of MRUS were filed in the last 90 days. 11 purchases are on record for this company.
How many insiders are selling MRUS stock?
No insider sales of MRUS were filed in the last 90 days. 5 sales are on record for this company.
Where can I see MRUS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks MRUS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow MRUS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add MRUS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - A/S Genmab view on EDGAR
- - A/S Genmab view on EDGAR
- - A/S Genmab view on EDGAR
- - A/S Genmab view on EDGAR
- - Gregory D. Perry view on EDGAR
- - Anand Mehra view on EDGAR
- - Len Kanavy view on EDGAR
- - Jason Haddock view on EDGAR
- - Peter B. Silverman view on EDGAR
- - Fabian Zohren view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where MRUS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track MRUS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
